Twenty-eight strains of Pseudomonas aeruginosa with various degrees of norfloxacin resistance were isolated from patients with urinary tract infections. P. aeruginosa strains (norfloxacin MICs, 3.13 to 200 ,ug/ml) were transformed by either pPAW207 or pNF111 plasmid DNA, which included either the gyrA or nfxB gene, respectively. For transformants with pPAW207, norfloxacin MICs decreased 8-to 128-fold. It was suggested that moderate and high degrees of resistance to norfloxacin were expressed as a result of alterations in gyrA. No strain manifesting only an alteration in nfxB permeability was observed. The MICs of norfloxacin (200 ,ug/ml) for two P. aeruginosa strains, GN17605 and GN17434-2, were decreased following transformation not only by pPAW207 but also by pNF111. Analysis of outer membrane proteins disclosed the presence of a 54,000-Da protein in these parent strains that was not expressed in the pNF111 transformants. The level of accumulation of norfloxacin by the pNF111 transformant of GN17605 was higher than that by the parent strain. The norfloxacin susceptibility of DNA gyrase subunit A purified from GN17605 was only 1/35th that of the gyrase containing a subunit A from P. aeruginosa PAO1. These findings suggest that GN17605 is a gyrA-nfjxB double mutant and that strain GN17434-2 possesses double mutations in both nfxB and some unknown gene.
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Quinolones have a broad spectrum of antibacterial activity against gram-positive and -negative bacteria and have strong bactericidal activities (2, 11, 16, 17) . These (3) . In addition, mechanisms of resistance, including alterations in both DNA gyrase and outer membrane permeability, have been reported recently in studies of clinical isolates of P. aeruginosa (8, 19 ).
In the study described here, P. aeruginosa strains isolated from patients with urinary tract infections were analyzed by transformation with plasmids carrying either a gyrA or a nfxB gene in order to determine the mechanisms of resistance to quinolones.
MATERIALS AND METHODS
Bacterial strains. Twenty-eight strains of norfloxacin-resistant (norfloxacin MIC, >1.56 ,ug/ml) P. aeruginosa originating from patients with urinary tract infections were used in the study. These strains were isolated between 1988 and 1991 from various hospitals in Japan and were maintained in glycerol at * Preparation of plasmid DNA and transformation. Plasmid pPAW207 containing the wild-type Escherichia coli gyrA gene and plasmid pNF1 11 containing the wild-type P. aeruginosa nfrB gene, which mediates the effects related to membrane permeability, were used for transformation (12, 19) . These plasmids were prepared by CsCl density gradient centrifugation. Competent cells of norfloxacin-resistant (norfloxacin MIC, >1.56 ,ug/ml) P. aeruginosa strains were prepared by using early-log-phase cells in L broth. Transformation was carried out with 100 mM MgCl2-treated P. aeruginosa (9) . The transformants were selected on bromthymol blue agar containing 400 ,ug of carbenicillin per ml, which was the selective marker for pPAW207 and pNF111 plasmids.
Characterization of outer membrane proteins. Outer membrane proteins of two clinical strains of P. aeruginosa, P. aeruginosa KH4013E, and pNF111 transformants were prepared by the method of Poxton et al. (13) . Fifty-microgram samples of proteins were subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis, and the gel was stained with Coomassie brilliant blue.
Norfloxacin accumulation by cells. The accumulation of norfloxacin by P. aeruginosa GN17605 and the pNF111 transformant were measured by a previously described method (6), ,ug/ml) after transformation with the pPAW207 (gyrA) plasmid. The increase in susceptibility to norfloxacin between parents and transformants was 8-to 128-fold. Similar changes in susceptibility were found for ciprofloxacin; in the case of strain GN17544, however, the increase in susceptibility to ciprofloxacin was fourfold greater than that to norfloxacin. No significant differences in the MICs of any of the agents other than carbenicillin (marker for resistance on the pPAW207 and pNF111 plasmids) were observed between parents and transformants.
Following transformation, the MICs of norfloxacin for both the pPAW207 and pNF111 transformants were decreased in the case of strains GN17605 and GN17434-2 (Table 1) . With the exception of these two strains, the MICs of norfloxacin for the pNF111 transformants were not decreased. For strain GN17605, susceptibility to norfloxacin increased 32-fold for the pPAW207 transformant and 8-fold for the pNF111 transformant. For the GN17434-2 strain, susceptibility to norfloxacin increased 16-fold for the pPAW207 transformant and 2-fold for the pNF111 transformant. Susceptibilities to ciprofloxacin for each pPAW207 and pNF111 transformant of GN17605 and GN17434-2 increased 128-, 8-, 64-, and 4-fold, respectively. In the case of both transformants, the MIC of carbenicillin was increased to >400 ,ug/ml, while susceptibili- ties to gentamicin and P-lactams (except for carbenicillin) were decreased in pNF111 transformants.
Outer membrane proteins of the pNF111 transformant. The outer membrane protein profiles of P. aeruginosa GN17605, GN17434-2, and KH4013E and the pNF111 transformants of these strains are shown in Fig. 1 . An outer membrane protein (54,000 Da) which was clearly detected in the GN17605 and GN17434-2 parent strains was not present after transformation by the pNF111 plasmid (arrow in Fig. 1 ). The amount of the 54,000-Da protein visualized in KH4013E (nfrB type mutant of PA04009) was decreased in the pNF111 transformant.
Norfloxacin accumulation by cells. The accumulation of norfloxacin by the pNF1 11 transformant of P. aeruginosa GN17605 was compared with that by the parent strain (Fig. 2) . Table 1) . DISCUSSION In members of the family Enterobacteriaceae, resistance to quinolones is often due to a reduction in drug permeation associated with a decrease in OmpF, the principal porin protein (4, 5, 15) . On the other hand, many mechanisms of resistance have been reported for P. aeruginosa (1, 3, 6, 10, 19) . Yoshida et al. (19) studied the proportion of gyr mutations in quinolone-resistant clinical isolates of P. aeruginosa and found that the gyrA mutation conferred various degrees of quinolone resistance on susceptible strains. Also in our study, strains of P. aeruginosa obtained various degrees (8-to 128-fold) of norfloxacin resistance by alteration of gyrA alone. Yoshida et al. (18) also reported that the degree of resistance to quinolones seems to be related to the site of mutation on the E. coli gyrA gene. Variation in the degree of resistance to norfloxacin by the P. aeruginosa clinical isolates used in the present study might be related to the site of mutation of the gyrA gene, as was the case for the E. coli gene noted above. It was observed that the rate of reduction in MICs by transformation with plasmid pPAW207 differed among norfloxacin, ciprofloxacin, and the other quinolone antibiotics (data not shown). This finding suggests that the effect of the gyrA mutation differed between compounds.
In addition to mutations in DNA gyrase, which appears to be the major factor for the determination of resistance to quinolones, decreases in drug permeation can also result in resistance to quinolones by P. aeruginosa. Chamberland et al. (1) (8) . In our study, no strain with only nfxB mutations, such as that reported by Jakics et al. (8) , was observed. We assumed that no strain had an nfxB mutation because most strains tested in the present study showed high-level resistance to norfloxacin, which differed from the case in the study of Jakics et al. (8) . However, for two strains, P. aeruginosa GN17605 and GN17434-2, the MICs of norfloxacin and ciprofloxacin were decreased by transformation not only with pPAW207 but also *1*... .1 with pNF111. This finding suggests the possibility of a double mutation in these two strains. Thus, they had a high degree of resistance to norfloxacin and ciprofloxacin by two different mechanisms, a decrease in the susceptibility of DNA gyrase subunit A (gyrA alteration) and a decrease in cell permeability (alteration of the outer membrane because of an nfxB mutation). Robillard (14) has reported clinical isolates of P. aeruginosa which featured a gyrA mutation coupled with a nongyrase A mechanism of resistance. However, no in-depth analysis was done on the strains that had two mutations. In the present study, sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the outer membrane proteins of GN17605 and GN17434-2 demonstrated the presence of a 54,000-Da protein. This protein was not present following transformation by the pNF111 plasmid. In addition, in P. aeruginosa GN17605, the accumulation of norfloxacin by the parent strain was less than that by the pNF111 transformant. These findings were in agreement with those of Hirai et al. (6) , and accordingly, the occurrence of a mutation typed for nfrB was proven for GN17605. We determined the susceptibility to norfloxacin of the DNA gyrase purified from GN17605 and found a reduction in the susceptibility of DNA gyrase subunit A to this antibiotic. Therefore, the alteration of the gyrA gene occurred along with that of the nfxB gene in P. aeruginosa GN17605. It is suggested that the results obtained for GN17434-2 will be the same as those obtained for GN17605.
In the present study, we demonstrated the presence among quinolone-resistant P. aeruginosa strains not only of strains with single mutations showing various degrees of resistance but also strains with double mutations. High degrees of resistance to quinolones in P. aeruginosa (norfloxacin MICs, 100 to 200 ,ug/ml) were caused by either a single mutation (gyrA) or a double mutations (gyrA-nfxB or another mutation) in the present study. These findings suggest the possibility that the mechanisms of resistance to quinolones in P. aeruginosa will be quite complex in the future.
